 |
Aspirin Reduces Recurrence of Venous Thromboembolism [ 12/Dec/11 ] |
|
|
Increased Incidence of Chronic GVHD and No Survival Advantage with Unrelated Donor PBSC Transplant versus Bone Marrow Transplant [ 11/Dec/11 ] |
|
|
As-Needed Treatment as Effective as Maintenance Therapy for Follicular Lymphoma [ 11/Dec/11 ] |
|
|
Gene Test Predicts Risk for Recurrence for Patients with DCIS [ 08/Dec/11 ] |
|
|
Advanced Breast Cancer First Consensus Conference: Update on New and Future Therapies for HER2+ Advanced Breast Cancer [ 04/Nov/11 ] |
|
|
Advanced Breast Cancer First Consensus Conference: Update on the State of the Art Management of HER2+ Metastatic Breast Cancer [ 04/Nov/11 ] |
|
|
Advanced Breast Cancer First Consensus Conference: Advanced Breast Cancer with Brain Metastasis Update [ 04/Nov/11 ] |
|
|
Everolimus enhances breast cancer survival with exemestane: BOLERO2 [ 26/Sep/11 ] |
|
|
KRAS mutations are prognostic markers for survival in advanced NSCLC [ 24/Sep/11 ] |
|
|
New Potential Anti-Cancer Compound Targets Tumor Cells by Depriving Them of Glucose [ 05/Aug/11 ] |
|
|
New susceptibility loci for adult asthma identified in the Japanese population [ 31/Jul/11 ] |
|
|
Genetic deletion length in chronic lymphocytic leukaemia matters [ 17/Jun/11 ] |
|
|
Anti-CCR4 monoclonal antibody provides encouraging results in Japanese patients with adult T-cell leukemia-lymphoma (ATL) [ 16/Jun/11 ] |
|
|
Fludarabine-mitoxantrone-rituximab (FMR) dose reduction feasible with radioimmunotherapy 90Y-ibritumomab tiuxetan (90Y-IT) consolidation in intermediate/high-risk follicular lymphoma [ 16/Jun/11 ] |
|
|
Neoadjuvant chemotherapy promising for high-grade soft tissue sarcomas in the extremities [ 05/Jun/11 ] |
|
|
Prognostic Factors for Japanese Advanced Gastric Cancer Patients [ 04/Jun/11 ] |
|
|
Cadi-05 added to paclitaxel plus cisplatin improved survival in NSCLC patients [ 04/Jun/11 ] |
|
|
Ganetespib Promising in NSCLC Patients with Actively Progressing Disease [ 04/Jun/11 ] |
|
|
Oncolytic Viruses Effective in Targeting and Killing Pancreatic Cancer Stem Cells [ 10/May/11 ] |
|
|
Telaprevir Effective in Hepatitis C Nonresponders and Relapsers [ 08/May/11 ] |
|
